BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33969621)

  • 1. The learning curve of transanal total mesorectal excision for rectal cancer is associated with local recurrence: results from a multicentre external audit.
    Van Oostendorp SE; Belgers HJE; Hol JC; Doornebosch PG; Belt EJT; Oosterling SJ; Kusters M; Bonjer HJJ; Sietses C; Tuynman JB
    Colorectal Dis; 2021 Aug; 23(8):2020-2029. PubMed ID: 33969621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
    Sun R; Cong L; Qiu HZ; Lin GL; Wu B; Niu BZ; Sun XY; Zhou JL; Xu L; Lu JY; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):522-530. PubMed ID: 35754217
    [No Abstract]   [Full Text] [Related]  

  • 3. Transanal total mesorectal excision (taTME) for rectal cancer: beyond the learning curve.
    D'Andrea AP; McLemore EC; Bonaccorso A; Cuevas JM; Basam M; Tsay AT; Bhasin D; Attaluri V; Sylla P
    Surg Endosc; 2020 Sep; 34(9):4101-4109. PubMed ID: 31602515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond transanal total mesorectal excision: short-term outcomes of transanal total mesorectal excision in locally advanced rectal cancer requiring resection beyond total mesorectal excision.
    Larach JT; Rajkomar AKS; Smart PJ; McCormick JJ; Heriot AG; Warrier SK
    Colorectal Dis; 2021 Apr; 23(4):823-833. PubMed ID: 33217140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locoregional recurrences after transanal total mesorectal excision of rectal cancer during implementation.
    van Oostendorp SE; Belgers HJ; Bootsma BT; Hol JC; Belt EJTH; Bleeker W; Den Boer FC; Demirkiran A; Dunker MS; Fabry HFJ; Graaf EJR; Knol JJ; Oosterling SJ; Slooter GD; Sonneveld DJA; Talsma AK; Van Westreenen HL; Kusters M; Hompes R; Bonjer HJ; Sietses C; Tuynman JB
    Br J Surg; 2020 Aug; 107(9):1211-1220. PubMed ID: 32246472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncological safety of transanal total mesorectal excision (TaTME) for rectal cancer: mid-term results of a prospective multicentre study.
    Simo V; Tejedor P; Jimenez LM; Hernan C; Zorilla J; Arrredondo J; Lapuente F; Pastor C
    Surg Endosc; 2021 Apr; 35(4):1808-1819. PubMed ID: 32333158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transanal (TaTME) vs. laparoscopic total mesorectal excision for mid and low rectal cancer: a propensity score-matched analysis of early and long-term outcomes.
    Munini M; Popeskou SG; Galetti K; Roesel R; Mongelli F; Christoforidis D
    Int J Colorectal Dis; 2021 Oct; 36(10):2271-2279. PubMed ID: 34467413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term outcomes after transanal total mesorectal excision for rectal cancer in Denmark - a prospective multicentre study.
    Klein MF; Seiersen M; Bulut O; Bech-Knudsen F; Jansen JE; Gögenur I
    Colorectal Dis; 2021 Apr; 23(4):834-842. PubMed ID: 33226722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-year outcome after transanal versus laparoscopic total mesorectal excision in locally advanced rectal cancer: a multicenter comparative analysis.
    de Lacy FB; Roodbeen SX; Ríos J; van Laarhoven J; Otero-Piñeiro A; Bravo R; Visser T; van Poppel R; Valverde S; Hompes R; Sietses C; Castells A; Bemelman WA; Tanis PJ; Lacy AM
    BMC Cancer; 2020 Jul; 20(1):677. PubMed ID: 32689968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of transanal total mesorectal excision (TaTME) versus laparoscopic TME for rectal cancer: A case matched study.
    Ye J; Tian Y; Li F; van Oostendorp S; Chai Y; Tuynman J; Tong W
    Eur J Surg Oncol; 2021 May; 47(5):1019-1025. PubMed ID: 33309105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structured training pathway and proctoring; multicenter results of the implementation of transanal total mesorectal excision (TaTME) in the Netherlands.
    Veltcamp Helbach M; van Oostendorp SE; Koedam TWA; Knol JJ; Stockmann HBAC; Oosterling SJ; Vuylsteke RCLM; de Graaf EJR; Doornebosch PG; Hompes R; Bonjer HJ; Sietses C; Tuynman JB
    Surg Endosc; 2020 Jan; 34(1):192-201. PubMed ID: 30888498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transanal versus conventional total mesorectal excision for rectal cancer using the IDEAL framework for implementation.
    Robertson RL; Karimuddin A; Phang T; Raval M; Brown C
    BJS Open; 2021 Mar; 5(2):. PubMed ID: 33889949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience beyond the learning curve of transanal total mesorectal excision (taTME) and its effect on the incidence of anastomotic leak.
    Caycedo-Marulanda A; Verschoor CP
    Tech Coloproctol; 2020 Apr; 24(4):309-316. PubMed ID: 32112245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review.
    Deijen CL; Tsai A; Koedam TW; Veltcamp Helbach M; Sietses C; Lacy AM; Bonjer HJ; Tuynman JB
    Tech Coloproctol; 2016 Dec; 20(12):811-824. PubMed ID: 27853973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transanal total mesorectal excision for stage II or III rectal cancer: pattern of local recurrence in a tertiary referral center.
    González-Abós C; de Lacy FB; Guzmán Y; Nogueira ST; Otero-Piñeiro A; Almenara R; Lacy AM
    Surg Endosc; 2021 Dec; 35(12):7191-7199. PubMed ID: 33398553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME).
    2017 European Society of Coloproctology (ESCP) collaborating group
    Colorectal Dis; 2018 Sep; 20 Suppl 6():33-46. PubMed ID: 30255642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes after transanal total mesorectal excision for rectal cancer in Denmark: A prospective multicenter study from the late implementation phase.
    Rehné Jensen L; Dohrn N; Seiersen M; Bulut O; Bech-Knudsen F; Erik Jansen J; Gögenur I; Falk Klein M
    Surg Oncol; 2023 Aug; 49():101967. PubMed ID: 37356316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term outcomes of transanal versus laparoscopic total mesorectal excision for mid-to-low rectal cancer: a meta-analysis.
    Zhang X; Gao Y; Dai X; Zhang H; Shang Z; Cai X; Shen T; Cheng X; Yu K; Li Y
    Surg Endosc; 2019 Mar; 33(3):972-985. PubMed ID: 30374790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-Year Nationwide Experience with Transanal Total Mesorectal Excision for Rectal Cancer in the Netherlands: A Propensity Score-Matched Comparison with Conventional Laparoscopic Total Mesorectal Excision.
    Detering R; Roodbeen SX; van Oostendorp SE; Dekker JT; Sietses C; Bemelman WA; Tanis PJ; Hompes R; Tuynman JB;
    J Am Coll Surg; 2019 Mar; 228(3):235-244.e1. PubMed ID: 30639298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Our experience with transanal total mesorectal excision (TaTME) procedures in middle and distal rectal tumors.
    Procházka V; Grolich T; Farkašová M; Čan V; Svatoň R; Svoboda M; Ostřížková L; Eid M; Frola L; Bohatá Š; Kala Z
    Rozhl Chir; 2020; 99(3):124-130. PubMed ID: 32349496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.